Oncolo-GIST for Critical Illness

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Critical Illness+2 More
Oncolo-GIST - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help to improve the way oncologists communicate with their patients who only have months left to live by teaching them to relay information both sensitively and using simple terminology.

Eligible Conditions
  • Critical Illness
  • Communication
  • Oncology

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 2 months, 4 months

2 months, 4 months
Patient Performance Status
Treatment and Care Received
Whether or not a Do Not Resuscitate was ordered by patient
Month 4
Change in Prognostic Understanding
Patient Quality of Life

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Oncolo_GIST Arm
1 of 2
Usual Care Arm
1 of 2
Experimental Treatment
Non-Treatment Group

58 Total Participants · 2 Treatment Groups

Primary Treatment: Oncolo-GIST · Has Placebo Group · N/A

Oncolo_GIST Arm
Behavioral
Experimental Group · 1 Intervention: Oncolo-GIST · Intervention Types: Behavioral
Usual Care Arm
Behavioral
PlaceboComparator Group · 1 Intervention: Usual Care Arm · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oncolo-GIST
2020
N/A
~20

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months, 4 months

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
521 Previous Clinical Trials
286,125 Total Patients Enrolled
9 Trials studying Critical Illness
2,464 Patients Enrolled for Critical Illness
Weill Medical College of Cornell UniversityLead Sponsor
983 Previous Clinical Trials
1,337,994 Total Patients Enrolled
5 Trials studying Critical Illness
733 Patients Enrolled for Critical Illness
Holly G Prigerson, PhDPrincipal InvestigatorWeill Medical College of Cornell University
3 Previous Clinical Trials
68 Total Patients Enrolled
1 Trials studying Critical Illness
20 Patients Enrolled for Critical Illness

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
We specialize in the diagnosis and treatment of lung and gastrointestinal cancers.
I currently provide care at the WCM Lung and GI cancer clinics.
and Spanish I am fluent in English and Spanish.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 31st, 2021

Last Reviewed: October 16th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References